Cancer survivor Katie Johnson Hoffman joins Carl Morrison, MD, DVM, and Linda Sabatini, PhD, for a discussion on how national initiatives in genetic research and advances in the field of personalized medicine are improving the outlook for cancer patients.
Dr. Morrison is Clinical Chief of the RPCI Department of Pathology & Laboratory Medicine, Director of Molecular Pathology and Director of the Pathology Resource Network.
